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1. Summary  
Artificial Intelligence (AI) has the potential to transform healthcare in various ways. It can turn 
large amounts of patient data into actionable information, improve public health surveillance, 
accelerate health responses, and produce leaner, faster and more targeted research and 
development (Raghupathi and Raghupathi, 2014). More specifically, AI in healthcare can support 
physicians; automate clinical documentation and image analysis, as well as assist with virtual 
observation, diagnosis and patient outreach (Gujral et al., 2019; Murali and PK, 2019; Jagdev 
and Singh, 2015).  
There are three broad categories for the uses of AI in healthcare (Paul et al., 2018; Raghupathi 
and Raghupathi, 2014): 
 Descriptive: this is currently the most widely used in healthcare technology. It involves 
quantifying events that have already occurred, and using this data to detect trends and 
other insights; 
 Predictive: this uses descriptive data to make predictions about the future, and 
 Prescriptive: this furthers the purpose of predictive AI, and not only detects trends but 
also suggests possible treatments in public health or more targeted clinical trials in 
research and development. 
Access to quality healthcare in developing countries, particularly in rural areas, is often a 
challenge that AI technologies have the potential to alleviate (Kalyanakrishnan et al., 2018). In 
India, rural populations may lack even basic healthcare facilities. Health technologies, such as 
telemedicine and AI in healthcare (including the use of robotics), can help resolve these 
disparities and reach underserved populations (Ajmera and Jain, 2019; Paul et al., 2018). India is 
in a unique position to be a leader in the AI and healthcare space, with large amounts of data 
and a growing start-up community specialising in harnessing AI to diagnose disease 
(Marketwarch, 2019).  
The healthcare industry in India is made up of various segments, including hospitals, 
pharmaceuticals, diagnostics, medical equipment and supplies, medical insurance, and 
telemedicine (Paul et al., 2018). Stakeholders in the adoption and implementation of AI in 
healthcare include practitioners, developers, research and industry bodies, government, and 
funders and investors (Paul et al., 2018). Large companies, such as Microsoft and Google, have 
also come together to work on a range of initiatives to help build AI infrastructure across the 
country (Marketwatch, 2019). They have conducted pilots with hospital chains in India (Murali 
and PK, 2019). Practo, an appointment booking app for patients in India has also been working 
on automating patient interactions with the use of AI (Murali and PK, 2019).  
It is important to explore the barriers to the implementation of AI in healthcare in India, so that it 
can be implemented successfully across the healthcare industry (Ajmera and Jain, 2019; Paul et 
al., 2018). While literature related to AI in healthcare in India – and on obstacles specifically -
seems to comprise of largely news reports, blog posts and conference and workshop 
proceedings, there are some academic studies on the topic. In addition, it is possible to draw 
from other literature on AI in healthcare in low-resource or low and middle income countries 
(LMICs); and from literature on the implementation of AI more generally in India. However, the 
literature does not allow for assessment of barriers across different stakeholders, aside from 
some mention of particular obstacles experienced by start-up companies. 
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The following are key barriers identified that can affect the implementation and growth of AI 
across the health sector in India. 
 The substantial cost, initial investment and infrastructure necessary to implement AI 
in healthcare is a key barrier. In India, the infrastructure required for AI to grow remains 
inadequate (Ajmera and Jain, 2019; Panch et al., 2019; Patil, 2018; Paul et al., 2018; 
USAID, 2019). 
 Challenges to working with big data, necessary for AI-driven healthcare include: the 
large number of unstructured data sets and problems with interoperability; the absence of 
open sets of medical data; inadequate analytics solutions capable of working with big 
data; and concerns that algorithms may generate data that reflect cultural biases (Ajmera 
and Jain, 2019; Jagdev and Singh, 2015; Mohandas, 2017; NITI Aayog, 2018; Paul et al., 
2018; Pinninti and Rajappa, 2020; Raghupathi and Raghupathi, 2014; USAID, 2019). 
Lack of access to open data sets is a particular challenge for start-ups (Paul et al., 2018). 
 Trust issues and apprehension with new technologies, particularly among the elderly, 
are often an obstacle to AI acceptance and usage. There is still a lack of understanding 
of AI and its benefits, among medical professionals and the general population (Paul et 
al., 2018, USAID, 2019). 
 An inadequate framework to ensure privacy, security, quality and accuracy of AI 
solutions in India is a large obstacle to adopting AI in healthcare. There are concerns in 
India about international companies gaining access to local data and leveraging it for 
their own uses, without local benefits. Issues of confidentiality and cybersecurity also 
need to be addressed, in order to prevent the compromise of sensitive health information 
(Ajmera and Jain, 2019; Bali and Bali, 2020; Gujral et al., 2019; Kamble et al., 2018; Paul 
et al., 2018; USAID, 2019; Walach, 2018).   
 Regulatory weaknesses and uncertainties remain a challenge. Insistence of proof of 
acceptable results in the form of costly and time-consuming clinical trials is a key 
obstacle for start-ups in India (Paul et. al; Pinninti and Rajappa, 2020). Liability for AI is 
also a key issue that needs to be resolved as, currently, liability falls solely on the 
doctor, rather than the technology (Paul et al., 2018; Mohandas, 2017).  
 Concerns over human job losses can contribute to lack of trust. In the healthcare 
sector in India, AI is often considered, however, to address the supply-demand gap and 
to act as an assistant to doctors (Murali and PK, 2019; Paul et al., 2018; Walach, 2018). 
The lack of AI trained professionals can also be a key barrier to using AI in healthcare 
(Ajmera and Jain, 2019; Patil, 2018). 
 Inequality concerns in the adoption of AI in healthcare in India include the under-
representation of minority groups in the data used to develop algorithms and solutions; 
the prominence of males in the software industry, resulting in a male bias in technologies; 
and greater benefits to higher income populations with access to technologies 
(Kalyanakrishnan et al., 2018; Panch et al., 2019; Wahl et al., 2018. 
2. Cost, investment, and infrastructure 
The advanced digital health infrastructure and automated technologies necessary to implement 
Artificial Intelligence (AI) in healthcare requires a substantial initial investment (USAID, 2019).  
This is a key barrier and concern to governments, health systems, potential investors, healthcare 
organisations and other stakeholders, particularly in lower-resource contexts, including India. 
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Few stakeholders have the resources to purchase AI tools at a price that would enable financial 
sustainability for the companies offering them (USAID, 2019).  
Public health organisations face mounting cost constraints and challenges in recruiting the talent 
and resources necessary for the development of artificial intelligence (Panch et al., 2019). 
Smaller organisations in the health sector also struggle, in particular, with limited resources and 
insufficient data backup systems (Ajmera and Jain, 2019; Patil, 2018).  
A survey conducted among healthcare and engineering professionals in Pakistan found that the 
cost of using such technologies in healthcare was a major concern (Hoodbhoy et al., 2019). This 
is similarly the case in India. A study on adopting big data analytics and AI in the manufacturing 
sector in India finds that cost is a key barrier to adoption, particularly among small and medium 
industries with inadequate funds for appropriate technologies (Kamble et al., 2018). 
While the Indian government has increased spending in the healthcare industry, the amount of 
public funding it invests in healthcare is small compared to other emerging economies (Jagdev 
and Singh, 2015). Government investment specifically in health-related AI in India is limited 
and research is under-funded and explored (Paul et al., 2018). The infrastructure necessary for 
AI to take off in India remains neglected by policy makers (Paul et al., 2018). Cloud-computing 
infrastructure, for example, is largely concentrated in servers outside India. Delays in investing 
in local infrastructure have resulted in many Indian start-ups incorporating themselves 
outside India, where they have easier access to infrastructure and technology (Paul et al., 
2018).  
Many diagnostic and therapeutic equipment are also imported from other countries to India, 
which can lead to software compatibility issues (Ajmera and Jain, 2019). Hospitals that do 
not have their own IT infrastructure can produce difficulties for managers using IT technologies 
(Ajmera and Jain, 2019). In rural areas of developing countries, infrastructure challenges are 
more pronounced. In some areas, electricity and internet are unavailable, which must be 
addressed in the designing process (Guo and Li, 2018). 
The lack of technological infrastructure throughout India also means that AI still lacks the deep-
learning capabilities that can overcome linguistic diversity across the country. This can be a 
significant impediment to the adoption of AI, particularly in healthcare (Paul et al., 2018). 
The government should encourage companies and the public sector to invest in AI by providing 
support and incentives (Paul et al., 2018). Public-private partnerships are essential, in order 
to avoid duplication of investment, particularly with limited resources (Panch et al., 2019; Paul et 
al., 2018). It is important to align the profit motive of private organisations with social 
responsibility and the advancement of public health (Panch et al., 2019). 
3. Data integrity 
Data lies at the core of AI-driven healthcare. Data integrity – the accuracy and completeness of 
data sets, used to power AI solutions, are essential for accurate and unbiased results (Paul et al., 
2018). Access to vital digitised patient data is required to optimise treatment via machine learning 
technology (Walach, 2018). There are several challenges in working with big data, including 
unstructured data, lack of interoperability, and unorganised data (Gujral et al., 2019). Even 
if it is possible to afford and implement costly infrastructure and AI tools in resource-poor 
settings, the efficacy of these tools can be inhibited by lack of necessary historical health data 
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and less health data overall relative to developed markets (USAID, 2019). For many diseases 
and conditions relevant to resource-poor settings, high-quality datasets that can be used to train 
machine learning algorithms to identify risk factors or make disease diagnoses can be difficult 
and time-consuming to collect. Health records are often hand-written in local languages, which 
may make it more challenging to digitise (Wahl et al., 2018). 
Data collection 
Data integrity requires particular attention in the Indian context, as a large number of data 
sets are unstructured and the population is diverse. Specific cultural biases, such as caste 
and sexuality, could be present in data sets. It is thus important that the data and input sources 
on which the AI technology’s algorithms are based and trained are derived from a sufficiently 
large and diverse population (Paul et al., 2018). 
There is a dearth of guidelines regarding data collection in India, however, especially in 
healthcare (Mohandas, 2017). This, in addition to errors of data entry and tabulation, is 
considered to be a key problem – as identified by AI and healthcare practitioners, start-ups and 
thank tanks at a workshop on AI in India (Mohandas, 2017).  
Data analysis 
Big data in healthcare refers to large and complex electronic health data sets that cannot be 
easily managed with traditional or software and/or hardware or common data management tools 
and methods (Raghupathi and Raghupathi, 2014). When big data in healthcare is synthesised 
and analysed, in order to reveal associations, patterns and trends, healthcare providers and 
other stakeholders in the healthcare delivery system can develop more thorough and insightful 
diagnoses and treatments (Raghupathi and Raghupathi, 2014). An obstacle to big data adoption 
in healthcare is the absence of an analytics solution powerful enough to gather massive 
volumes of largely unstructured health data, perform complex analyses quickly, and trigger 
meaningful solution (Jagdev and Singh, 2015). For example, gathering and uploading all the data 
from intensive care unit monitors, deciphering significant medical patterns and triggering a 
medical action (Jagdev and Singh, 2015). 
Big data in healthcare is overwhelming not only due to its volume, but also because of the speed 
at which it must be managed and the diversity of data types (Raghupathi and Raghupathi, 2014). 
Data types include various clinical data (e.g. physician’s written notes and prescriptions, medical 
imaging etc.), patient data, machine generated data (e.g. monitoring vital signs), as well as social 
media posts, web pages etc. (Gudivada and Tabrizi, 2018; Raghupathi and Raghupathi, 2014). 
Most available databases are not robust in terms of quality to be used for AI algorithms (Pinninti 
and Rajappa, 2020).  
Lack of open data 
Access to data is essential for AI implementation (Paul et al., 2018). India has extensive amounts 
of health data available (NITI Aayog, 2018). Unstructured data, such as output from medical 
devices, doctors’ notes, lab results, imaging reports, medical correspondence, clinical data and 
financial, comprises close to 80% of information in the healthcare industry (Jagdev and Singh, 
2015, 32). Getting access to this data is an invaluable resource for improving patient care and 
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increasing efficiency (Jagdev and Singh, 2015). India lacks, however, a structured regime in 
terms of sharing health-related data (NITI Aayog, 2018).  
A key obstacle to the adoption and implementation of AI in healthcare in India is the 
absence of robust open sets of medical data (Gujral et al., 2019; NITI Aayog, 2018). 
Accessing large medical datasets can be difficult, for legal and other reasons. This is a 
particular challenge for start-ups, in particular, as larger actors often already have access to 
such data (Paul et al., 2018). Start-ups thus often rely instead on publicly available datasets 
from the US, Europe, and elsewhere (Paul et al., 2018; Mohandas, 2017). This undermines the 
effectiveness of using AI in healthcare, however, as the demography represented in the data set 
is significantly different from the population in India and does not cater to the Indian 
demographic (Paul et al., 2018; Mohandas, 2017). Reliance on open data from other contexts 
results in algorithms that reflect the bias of such data and development of solutions trained to a 
specific demographic (USAID, 2019; Paul et al., 2018). It would be necessary to adjust for these 
biases in the application of AI tools and to retrain solutions on Indian data, particularly when it 
involves drug discovery and genomics (USAID, 2019; Paul et al., 2018). While there are some 
scattered examples of open source data in the Indian context, such as the state of Tamil Nadu 
and the National Cancer Registry, they are insufficient (Mohandas, 2017).  
Start-ups in the medical field also face issues in accessing data from outside of India. Data 
protection laws, in the EU for example, prevent interoperability. This has made start-ups wary of 
the cost and consequences of dealing with medical data (Paul et al., 2018). 
Interoperability 
A key data challenge for AI healthcare applications in healthcare in LMICs, stems from the 
general lack of digital health data and integration of data across diverse sources (USAID, 2019). 
Such AI-enabled tools require data from diverse sources in order to ensure comparability of data, 
and to produce large training data sets needed for accuracy of algorithms (USAID, 2019).  
Healthcare data remains highly dispersed and siloed, spread across a range of 
organisations – including hospitals, clinics, nursing homes, pharmacies, testing laboratories and 
IT vendors, and found in incompatible systems and proprietary software (Winter and Davidson, 
2019; Walach, 2018). Systems differ even within hospitals across LMICs (USAID, 2019).  
This results in the absence of data standardisation and interoperability (the ability of multiple 
systems or components to exchange information and to use this information). Lack of 
interoperability represents a key barrier to data sharing and data use – including use in advanced 
analytics and AI applications, and to the implementation of AI in healthcare (USAID, 2019; Winter 
and Davidson, 2019; Walach, 2018). 
In India, the healthcare industry is rarely standardised, resulting in fragmented and non-
standardised clinical data.  Although India has adopted an electronic health record (HER) policy, 
implementation of this policy has yet to be harmonised across relevant segments of the 
healthcare sector. This leads to different interpretations of digitising records and the absence of 
comprehensive implementation across all hospital data (NITI Aayog, 2018; Paul et al., 2018). 
The absence of collaborative efforts between various stakeholders exacerbates this obstacle 
(NITI Aayog, 2018). 
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Multiple users  
The complexity of extracting medical data increases along with the specificity and ambiguity of 
medical languages. This difference can cause vernacular mismatches between queries and 
documents, often rendering AI algorithms ineffective (Gudivada and Tabrizi, 2018). The model 
needs not only to be trained with the proper domain knowledge to associate related terms, but 
must also cater to people with and without the medical terminology background, and with and 
without technical experience (Gudivada and Tabrizi, 2018). 
4. Trust issues 
Lack of trust is a consistent theme underlying many discussions around AI and other digital 
health tools in LMICs (USAID, 2019). Trust issues and apprehension are often an obstacle to 
AI acceptance and usage (Paul et al., 2018). 
In India, the doctor-patient relationship is often one where the doctor is held in high 
authority and given complete trust. Patients want doctors to be physically present. This is 
particularly the case with a significant part of the population poor and illiterate (Paul et al., 2018). 
The elderly are also often more averse to adopting new technology. If doctors are to rely 
more in AI to inform their decisions and actions, AI system actions need to be explainable and 
easily understandable by humans. This is especially important in healthcare, where diagnosis 
and treatment must be backed by a solid chain of reasoning to earn patient trust (Paul et al., 
2018). There is currently little guidance, however, around when and how to provide explainability 
– including the range of factors upon which AI bases its decisions, what the desired outcomes 
are, how AI prioritises needs when making its decisions, and what the logic of a decision taken or 
recommended by an AI system is (Paul et al., 2018). 
Employees working in the health sector may also still be unclear about the potential 
benefits of AI in terms of value and faster delivery of services. Particularly as certain 
technologies are still in the early stages of development, with uncertain outcomes (Ajmera and 
Jain, 2019). AI-based healthcare solutions also often face the issue of information asymmetry 
between the doctors who use the system and the coders who built it, which may result in 
hesitation among healthcare professionals in adopting the software (Paul et al., 2018). 
5. Data protection, privacy, and cybersecurity 
Responsible and ethical AI is a key issue that must be considered by developers, practitioners, 
and policy makers when designing, using, and regulating AI (Paul et al., 2018). Data security, 
data privacy and ethical use of data represent global challenges and are of significant 
concern in developing countries (Ajmera and Jain, 2019; USAID, 2019; Kamble et al., 2018).  
This is not only for those working in AI specifically, but also for those working in digital health and 
other related sectors (USAID, 2019).   
India currently does not have an adequate framework to ensure privacy, security, quality, 
and accuracy of AI solutions, which is a large obstacle to gaining benefits from the adoption of 
AI in healthcare (Bali and Bali, 2020; Gujral et al., 2019; Paul et al., 2018). Industry professionals 
have pointed out the importance of standard design guidelines for future AI systems, which is 
lacking in India (Paul et al., 2018). Existing public health data governance structures in India are 
unlikely to be sufficient to control the combined momentum of AI, deep learning and data 
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aggregation, or thus to help channel developments along societally beneficial and equitable 
directions (Gujral et al., 2019; Winter and Davidson, 2019). Problems with standardisation of 
digitised health data and interoperability, discussed above, and lack of formal regulation around 
anonymisation of data, also contribute to ineffective health data governance (Gujral et al., 2019; 
NITI Aayog, 2018). While the absence of such regulation has allowed for greater flexibility 
for start-up companies to collect data and adopt self-regulatory practices of anonymising data 
prior to further use, the regulatory vacuum produces uncertainty about potential changes 
(Paul et al., 2018).  
For further discussion about regulatory issues, see Section 6. 
Data protection and privacy 
Healthcare information is deemed to be sensitive data under Indian sectoral law (Dixon, 2017). 
Information privacy concerns are identified as a tremendous obstacle to big data adoption 
in healthcare in India (NITO Aayog, 2018; Jagdev and Singh, 2015). A key step towards 
ensuring privacy and security of healthcare data is for India is to enact and effectively enforce a 
comprehensive privacy legislation (Paul et al., 2018). Data privacy issues are particularly 
important in the health sector since health data is usually government owned, raising concerns 
about private companies, particularly larger companies, gaining access to such data and 
possibly leveraging it for their own uses (USAID, 2019). There are concerns in India that 
international companies in the past have drawn on intangible knowledge from the healthcare 
sector in India in order to develop a hospital information system using the resources of Indian 
hospitals. However, these same hospitals were later not able to access these products they 
helped to develop, having to buy licenses for the next versions of the same or similar products 
(Bali and Bali, 2020). 
The development of a data protection law in India is currently underway. This, along with the 
promotion of local innovators and leaders in AI technologies, are crucial steps to ensure that the 
big data generated in India is used to empower local populations and provide them with services, 
rather than to exploit them for commercial gains (Bali and Bali, 2020).  
Issues of confidentiality also need to be addressed in the context of AI in healthcare. Norms 
must be established to deal with confidentiality in the doctor-patient-AI relationship, informed 
consent (for use of and access to personal health data) and standards for AI driven medical 
research (Paul et al., 2018).  
Consent for collection is a key data challenge (Paul et al., 2018). Experience with the roll out of 
the Aadhaar biometric identity card in India, launched in 2009 and aimed at developing a 
centralised database with the stated goals of delivering services, reducing fraud and increasing 
efficiencies, is also concerning in terms of privacy and consent. Research has shown that the 
lack of protective policy allowed the ID to go from voluntary to mandatory, without appropriate 
data privacy protections (Dixon, 2017). Technical deployment seemed to precede policy 
development, adequate privacy legislation, and ethics constraints (Dixon, 2017). The Aadhaar 
Act (2016) and other existing regulations fail to provide robust consent provisions in regards to 
the collection of biometrics (Dixon, 2017). 
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Cybersecurity 
The large amounts of confidential health information available online across the cloud computing 
environment, necessary to adopt AI in the health sector, also pose a security risk. Cybersecurity 
concerns represent one of the largest barriers for successful implementation of adopting 
AI in the health sector (Ajmera and Jain, 2019). Cyberattacks on all types of organisations 
globally are on the rise, rendering private digitised data vulnerable to being hacked and accessed 
by other parties (Ajmera and Jain, 2019; Kamble et al., 2018; Paul et al., 2018; Walach, 2018). 
The hacking of a Mumbai-based diagnostic laboratory database in 2016, for example, resulted in 
the leaking of medical records of over 35,000 patients from across India. Despite prior hacks, the 
laboratory had not taken action to secure the data (Paul et al., 2018).  
The security and accuracy of AI solutions in the health sector must be ensured, as the 
compromise of highly sensitive health information can have detrimental consequences, 
with individual lives at stake (Walach, 2018; Paul et al., 2018). This requires much higher privacy 
and security standards regulating sensitive personal information in India; robust security 
protocols and requirements for breach notification, and the development of secure infrastructure 
by AI companies for processing patient data (Paul et al., 2018; Walach, 2018). 
6. Regulatory implications 
AI is still an emerging field worldwide. As such, many LMICs lack consistent regulations for the 
use of AI tools by various actors and AI providers (USAID, 2019). This variability and uncertainty 
in the regularity environment impedes the scale-up of AI technologies (USAID, 2019). 
Regulatory weaknesses are a challenge to the implementation and adoption of AI in India. 
These challenges include the lack of a Regulating Authority for AI in healthcare, and the need for 
an appropriate certification mechanism (Paul et al, 2018). Given that AI is not limited to any one 
subject or aspect, there is also a need for self-regulation and/or for the use of different regulators 
for different aspects – such as for the medical aspect, the Medical Council of India, and for the 
data aspect, a new regulator under the Data Protection Bill (Mohandas, 2017). 
It is also the case that existing legislation in India, and other LMICs, that require physicians to 
make diagnoses and highly trained health workers to carry out certain medical tests can negate 
the value of certain AI tools (USAID, 2019). 
As with any new technology in healthcare, AI needs to be subject to regulatory approvals relying 
on clinical trial and evidence-based improvements in clinical outcomes among targeted 
populations (Pinninti and Rajappa, 2020). The acceptability of results arrived at using AI is 
one of the biggest issues with adoption of AI in healthcare in India (Paul et al., 2018). Start-
ups in the field often find that they are required to show proof of a clinical trial when 
presenting their products to doctors and hospitals in order to gain the trust of medical 
practitioners. Yet clinical trials are not tailored for AI technologies (e.g. medical devices and 
digital health platforms) and are both cost and time consuming (Paul et al., 2018). Further, there 
is no clear regulation to adhere to in conducting such clinical trials (Paul et al., 2018; Mohandas, 
2017). An appropriate certification system is required to address the security and quality of 
healthcare systems driven by AI. It can help to build trust amongst health practitioners and 
patients (Paul et al., 2017). 
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A possible solution is for doctors and start-ups to partner to conduct clinical trials (Paul et al., 
2018; Mohandas, 2017). In addition, a ‘regulatory sandbox’ could be adopted, which is a testing 
box with relaxed regulations to allow a product to be launched. This can offer an incentive to 
people working in the field of AI and health to innovate and to receive certification (Mohandas, 
2017). 
Liability and accountability 
Laws about liability for AI must be considered, and issues around liability resolved when 
deploying a digital strategy (Kamble et al., 2018). In the case of error in diagnosis malfunction of 
a technology, or the use of inaccurate data, a critical question is upon who would the liability fall 
– the doctor or the software developer? In cases of medical negligence in India, liability falls on 
the medical professional, who can be prosecuted under civil and criminal law (Paul et al., 2018; ; 
Mohandas, 2017). However, it is unclear how to determine the level of accountability and liability 
of the doctor when he/she provides the wrong diagnosis and/or treatment due to a glitch in the 
system or an error in data entry. In the case of AI in healthcare, many believe that the creator 
of software should be an agent that can be regulated (Paul et al., 2018; Mohandas, 2017). 
There should also be guidance on defining boundaries in healthcare where AI would not be 
allowed to take over (Mohandas, 2017). 
The accurate and unbiased architecture of an AI solution and its underlying algorithm is also 
important in ensuring responsible AI in healthcare. As India considers a data protection 
framework, appropriate forms of oversight over algorithms have been considered, with one 
proposal suggesting an accountability model that would audit algorithms to ensure they are 
privacy neutral and inclusive (Paul et al., 2018). 
7. Employment and skills-set 
Worker replacement concerns 
Concerns that automated and robotic technologies will lead to human job losses can 
contribute to lack of trust in and support for the adoption of AI in healthcare (Ajmera and Jain, 
2019). Negative press reports in India claiming that AI poses a threat to jobs has resulted in 
difficulty for start-ups to acquire funding (Paul et al., 2018). There is no substantial research, 
however, to assess the impact of robotics on the employment and motivation of employees in the 
healthcare sector (Qureshi and Syed, 2014). A survey of professionals in Pakistan finds that few 
respondents consider the phenomenon of computers replacing human jobs to be a concern or a 
barrier to using AI in healthcare. The vast majority believed instead that it would help to augment 
human intelligence (Hoodbhoy et al., 2019). 
Some media articles emphasise that AI-based healthcare initiatives are not designed to 
replace doctors in India, but to serve as assistants to doctors and to bridge the demand and 
supply gap between patients and doctors (Murali and PK, 2019; Marketwatch, 2019; Walach, 
2018). They are also aimed at extending medical services to traditionally underserved 
populations in the country, such as in rural areas, and thus to address issues of economic 
disparity (Marketwatch, 2019). 
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Skilled workforce 
A skilled healthcare workforce and specialised training are required to handle automated 
smart machines, digitisation of data, and successful implementation of AI in healthcare 
(Ajmera and Jain, 2019). The need to handle sensitive health information very carefully requires 
a workforce specifically trained to protect data theft (Ajmera and Jain, 2019). Readily available 
informaticians and analysts may not have the necessary skills to give required support, which 
can leave a lot of information unaccounted for, and undermine the ability to use AI systems 
effectively and to determine optimal results (Patil, 2018). A survey of local professionals in 
Pakistan finds that a lack of trained AI professionals is the most commonly cited barrier to 
using AI in healthcare (Hoodbhoy et al., 2019). This is also considered a key need in the 
manufacturing sector in India – prerequisite knowledge that cuts across various technical and 
non-technical disciplines (Kamble et al., 2018). Healthcare sectors worldwide should invest in 
skills training and development of their human resources, which in turn would motivate the 
healthcare professionals to work in tandem with robots (Qureshi and Syed, 2014) 
8. Inequality concerns 
Large datasets are essential to the development of AI technologies, but must be representative 
of the population to ensure all can benefit (Panch et al., 2019). Minority groups tend to be less 
represented in datasets used to develop AI algorithms. The derivation of health solutions are 
thus unlikely to be representative of these populations (Panch et al., 2019).  These challenges 
are exacerbated by the fact that many AI algorithms are considered a ‘black box’ and less likely 
to be assessed for bias (Wahl et al, 2018).  
Some experts have raised concerns that AI applications in healthcare could exacerbate 
gaps and inequities in Indian society, including those related to ethnicity, socioeconomic 
status and gender (Kalyanakrishnan et al., 2018; Wahl et al., 2018). Cultural prejudices can be 
reflected in data, algorithms and other aspects of AI design (Wahl et al., 2018). Algorithms can 
generate data that may be based on race, gender, age, and religion, resulting in 
discrimination and unfair results which might be better for some demographics in India than 
others (Pinninti and Rajappa, 2020). 
Issues with bias in datasets are compounded in India by the concern that gender ratios in 
India’s software industry are heavily skewed, resulting in the risk that AI technologies to be 
utilised by the entire population will be produced with a strong male bias (Kalyanakrishnan et al., 
2018). 
Broader sections of the population, particularly women, linguistic minorities, and rural 
communities, must be trained in these areas to help reduce the potential for biases and to create 
and maintain AI systems for their own needs (Kalyanakrishnan et al., 2018; Wahl et al., 2018). 
The adoption of AI-enabled healthcare tools also run the risk of further marginalising 
underserved populations in the short term as benefits will go initially to higher-income 
segments of the population - those with smartphones and 4G connectivity (USAID, 2019). In 
South Asia, this could also inadvertently exacerbate the gender disadvantage as women are less 
likely to own a mobile phone than men (Kalyanakrishnan et al., 2018). Further, there are 
concerns that the high costs of developing AI-based applications may mean that private 
corporations will be the key drivers. They may be more focused on catering to demographics with 
larger profit potentials, with no obligation to ensure equitable access (Kalyanakrishnan et al., 
12 
2018). Equity must be central to the development and implementation of AI, and access to AI 
applications across health systems (Panch et al., 2019) 
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